Crown Bioscience Blog (2)

News & Insights
Contact Us
Databases

Services
About Us
Our Science
- Resources
- Blog
Contact Us

Blog

Accelerating Cancer Drug Discovery with Digital Pathology-Based Biomarker Analysis

Accelerating Cancer Drug Discovery with Digital Pathology-Based Biomarker Analysis

September 14, 2021

In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors

In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors

September 1, 2021

Next-Generation Sequencing in Cell Line and Biosample Authentication

Next-Generation Sequencing in Cell Line and Biosample Authentication

August 16, 2021

In vivo preclinical models for immune-mediated inflammatory disease drug development

In vivo preclinical models for immune-mediated inflammatory disease drug development

August 2, 2021

Preclinical Models for Bispecific T Cell Engager Development

Preclinical Models for Bispecific T Cell Engager Development

July 5, 2021

Ask the Expert: Organoid and Immune Cell Co-Cultures

Ask the Expert: Organoid and Immune Cell Co-Cultures

June 1, 2021

For the Children: Advancing the Cause of Pediatric Cancer Research

For the Children: Advancing the Cause of Pediatric Cancer Research

May 4, 2021

Expanding the Horizon of Antibody-Drug Conjugates for Cancer Treatment

Expanding the Horizon of Antibody-Drug Conjugates for Cancer Treatment

April 1, 2021

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

March 1, 2021

Factors to Consider When Selecting a Next Generation Sequencing (NGS) Technology

Factors to Consider When Selecting a Next Generation Sequencing (NGS) Technology

December 18, 2020

View Recent Posts View Older Posts

Search our Blog

Categories

© 2022 Crown Bioscience.

Terms of Use
Privacy Statement